VIVO and CB2 Insights Enter Technology and Research Partnership

Partnership to focus on implementing a medical product development strategy for VIVO’s global medical cannabis offering, utilizing CB2 Insights’ leading technology platform Sail and research capabilities Joint venture will...
- October 29th, 2019 at 7:56 am

Tracking Cannabis Company Profitability

This is a copy of the May 19th edition of our weekly Newsletter, which we have been publishing since October 2015. Friends, One of the big criticisms of the...
- May 19th, 2019 at 9:24 am

CB2 Insights Retires Convertible Debentures

TORONTO, March 13, 2019 (GLOBE NEWSWIRE) — CB2 Insights Inc. (“CB2” or the “Company”) (CSE:CBII), has completed the conversion of 100% of its outstanding Convertible Senior Secured Debentures entered...
- March 13th, 2019 at 4:31 pm